GlassScriptPhysician profile
Joel William Baker
NPI 1588610638
$1,123.28
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $761 · 2022: $52.25 · 2023: $145 · 2024: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $616.88 | 2019 | |
| Pfizer INC. | $84.47 | 2024 | |
| Hologic Sales and Service, LLC | $63.54 | 2019 | |
| Abbvie INC. | $58.05 | 2019-2022 | |
| Astellas Pharma US INC | $56.83 | 2019-2023 | Veozah |
| Applied Medical Resources Corporation | $41.96 | 2024 | |
| Axonics, INC. | $41.26 | 2023 | Axonics, Bulkamid |
| Coopersurgical, INC. | $40.20 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Kowa Pharmaceuticals America, INC. | $31.92 | 2023 | Seglentis |
| Therapeuticsmd, INC. | $24.03 | 2019 | |
| Sumitomo Pharma America, INC. | $17.67 | 2024 | Myfembree |
| Meditrina | $15.84 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.35 | 2022 | |
| Merck Sharp & Dohme LLC | $15.28 | 2023 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.